Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00736086 · ClinicalTrials.gov registry record
RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System
A clinical trial of Cardiovascular Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 165
- Enrollment target
- 11
- Study locations
NCT00736086: Completed study of Cardiovascular Disease and Peripheral Vascular Disease, sponsored by Abbott Medical Devices.
NCT00736086 is a study of Cardiovascular Disease and Peripheral Vascular Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 165 participants, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (94% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00736086, a study of Cardiovascular Disease and Peripheral Vascular Disease, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
- 11
- Study locations
Study Summary
To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.
Conditions Studied
Interventions
- DEVICE Vessel Closure (StarClose™)
Study Locations (11)
New York
- New York Methodist Hospital - Brooklyn
- Buffalo Heart group - Buffalo
California
- Scripps Memorial Hospital - La Jolla
Georgia
- Fuqua Heart Center/ Piedmont Hospital - Atlanta
Illinois
- Heart Care Midwest (OSF/St Francis) - Peoria
Indiana
- The Care Group LLC (St. Vincent's Hospital) - Indianapolis
Michigan
- Bay Regional Medical Center - Bay City
Minnesota
- Minneapolis Heart Institute Foundation/Abbott Northwestern Hospital - Minneapolis
Missouri
- St. Luke's Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2006-03 |
| Est. Completion | 2006-12 |
What the finished NCT00736086 record still lists
NCT00736086 is an observational study that tracks outcomes without assigning an intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 2,696-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Vessel Closure (StarClose™) is the first listed.
NCT00736086 lists 11 locations in 10 states (New York, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT00736086 about?
NCT00736086 is a clinical study titled "RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System". To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.
What is the current status of trial NCT00736086?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2006-03. Estimated completion is 2006-12.
What conditions does trial NCT00736086 study?
This clinical trial studies the following conditions: Cardiovascular Disease, Peripheral Vascular Disease.
What interventions are being tested in trial NCT00736086?
The interventions under investigation include: Vessel Closure (StarClose™) (DEVICE).
Who is sponsoring clinical trial NCT00736086?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00736086 being conducted?
This trial has 11 study locations across California, Georgia, Illinois, Indiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00736086's enrollment target sits among peer trials
165 57th of 137 higher than 81 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
WISE CVD - Continuation (WISE HFpEF)
RECRUITING
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RECRUITING · Phase 3
-
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
RECRUITING
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia